Evodiamine

Tlhaloso e Khutšoanyane:

Evodiamine ke bioactive alkaloid extract ho tloha semela se bitsoang Evodia rutaecarpa (Juss.). Ena ke setlama sa Machaena se bitsoang Wu-Chu-Yu seo lingaka tsa litlama tsa Machaena li se sebelisitseng ka makholo a lilemo e le tlatsetso ea ho theola boima ba 'mele.Evodia extract ke e bonolo, empa e le e tsotehang e susumetsang e bontšitseng matla a matle le litšobotsi tsa diuretic. Ho khahlisang le ho feta ke bokhoni ba eona bo ikhethang ba ho phahamisa haholo tlhahiso ea mocheso oa 'mele le ho eketsa mocheso oa mantlha oa ho phomola.


  • FOB Theko:US $0.5 - 2000 / KG
  • Bongata ba Odara:1KG
  • Matla a Phepelo:10000 KG/Kgwedi
  • Boema-kepe:SHANGHAI/BEIJING
  • Melao ea Tefo:L/C,D/A,D/P,T/T
  • :
  • Lintlha tsa Sehlahisoa

    Li-tag tsa Sehlahisoa

    Lebitso la Sehlahisoa:Evodiamine

    Lebitso le Leng:Evodiamine, Isoevodiamine, (+)-Evodiamine, d-Evodiamine,Fructus Evodiae Extract

    Nomoro ea CAS:518-17-2

    Tekanyetso: 98% Min

    'Mala: Phofo e khanyang ea kristale e 'mala o mosehla

    Ho paka: ka meqomo ea fiber ea 25kgs

    Polokelo: Boloka setshelo se sa buloa sebakeng se phodileng, se omileng, Qoba hole le leseli le matla

    Shelf Life: Likhoeli tse 24 ho tloha ka letsatsi la tlhahiso

     

    Evodiamine ke alkaloid e ikhethang ea bioactive le motsoako oa mantlha oa bioactive meriana ea setso ea Machaena. E fumanoa ka monokotsoai oa semela sa Evodia evodia, se hōlang haholo-holo Chaena le Korea. E fumanoa ka monokotsoai oa semela sa Evodia evodia, se hōlang haholo-holo Chaena le Korea. Semela sena se na le mefuta e mengata ea lik'hemik'hale 'me esale se sebelisoa meriana ea setso ea Machaena ho phekola mathata a fapaneng a bophelo bo botle, ho kenyelletsa le mathata a tšilo ea lijo, ho ruruha le bohloko. Evodiamine e sebetsa ka ho shebana le litsela tse fapaneng tsa limolek'hule 'meleng. E tsebahala ka ho hlohlelletsa ts'ebetso ea li-receptor tsa vanillin, tse bapalang karolo ea bohlokoa temohong ea bohloko le thermogenesis. Ho feta moo, ho fumanoe hore e sebelisana le serotonin le li-receptor tsa dopamine, tse fanang ka maikutlo a hore e na le thepa ea ho ntlafatsa maikutlo.

     

    Mosebetsi oa likokoana-hloko: Evodiamine ke alkaloid e arohaneng le litholoana tsa Bentham, tse nang le mesebetsi e fapaneng ea likokoana-hloko tse kang ho thibela ho ruruha, ho thibela botenya, le ho thibela hlahala. In vitro: Evodiamine e bontšitse cytotoxicity khahlano le mela e fapaneng ea lisele tsa mofetše oa motho ka ho etsa hore apoptosis. Ho phaella moo, ke molek'hule ea tlhaho e khahlanong le hlahala e nang le sepheo se sengata e sebetsang khahlanong le hlahala ka mekhoa e fapaneng ea limolek'hule tse kang litsela tse itšetlehileng ka caspase le tse sa itšetleheng, tsela ea sphingomyelin, pontšo ea calcium / JNK, 31 PI3K / Akt / caspase, le Fas. -L/. NF – κ B tsela ea pontšo 32 [1]. Ka vivo: Evodiamine e thibela metabolism ea dapoxetine. Ha ho bapisoa le sehlopha sa taolo, t1/2, AUC (0- ∞), le Tmax pharmacokinetic parameters ea dapoxetine sehlopheng sa evodiamine e ile ea eketseha haholo ka 63.3%, 44.8%, le 50.4%, ka ho latellana. Ho phaella moo, evodiamine e fokolitse haholo t1 / 2 pharmacokinetic parameters le AUC (0- ∞) ea demethylated dapoxetine [2]. Evodiamine e thibela ho hōla ha hlahala ka subcutaneous H22 xenograft model. Evodiamine e kokobetsa VEGF induced angiogenesis in vivo.

     

    In vitro: Evodiamine e bonts'a cytotoxicity khahlano le mela e fapaneng ea lisele tsa mofetše oa motho ka ho susumetsa apoptosis. Ho phaella moo, ke molek'hule ea tlhaho e khahlanong le hlahala e nang le sepheo se sengata e sebetsang khahlanong le hlahala ka mekhoa e fapaneng ea limolek'hule tse kang litsela tse itšetlehileng ka caspase le tse sa itšetleheng, tsela ea sphingomyelin, pontšo ea calcium / JNK, 31 PI3K / Akt / caspase, le Fas. -L/. NF – κ B tsela ea pontšo 32 [1].

    Ka vivo: Evodiamine e thibela metabolism ea dapoxetine. Ha ho bapisoa le sehlopha sa taolo, t1/2, AUC (0- ∞), le Tmax pharmacokinetic parameters ea dapoxetine sehlopheng sa evodiamine e ile ea eketseha haholo ka 63.3%, 44.8%, le 50.4%, ka ho latellana. Ho phaella moo, evodiamine e fokolitse haholo t1 / 2 pharmacokinetic parameters le AUC (0- ∞) ea demethylated dapoxetine [2]. Evodiamine e thibela ho hōla ha hlahala ka subcutaneous H22 xenograft model. Evodiamine e kokobetsa VEGF induced angiogenesis in vivo.

     

    MOSEBETSI:

    Mesebetsi e khahlanong le ho ruruha, anti-tumor, le hypoglycemic e na le litlamorao tse itseng tsa kalafo kalafong ea 'dementia' ea pele le stroke. E na le analgesic, e theola khatello ea mali 'me e baka ho phahama ho hoholo ha mocheso oa' mele. Tšebeliso ea bongaka ea sehlahisoa sena ke ho hlahisa li-agent tsa bongaka bakeng sa diuretics le mofufutso.

    1. Evodia extract e sebelisetsoa ho phekola matšoao a ho tsieleha ka mpeng. Tsena li kenyelletsa ho nyekeloa ke pelo, ho hlatsa le letšollo. Ho boleloa hore e sebetsa ka ho khetheha ho phekola letšollo la hoseng.

    2. Evodia e sebelisetsoa ho tsosa takatso ea lijo le ho phekola matšoao a ka mpeng a amanang le ho hloka thahasello lijong.

    3. Evodia extract e boetse e na le anti-inflammatory, anti-tumor, anti-viral, astringent, le diuretic properties.

    4. Evodiamine e nang le analgesia, ho theola khatello ea mali le ho phahama ha mocheso oa 'mele le liphello tse ling tsa meriana.

    5. Evodiamine e na le stomachic, stop retching, oxyrygmia effect le diuretic effect.

    6.Evodiamine e na le phello e matla ea ho thibela ho li; le phello e kholo ea likokoanyana ho ascarissuum;

    7.Evodiamine hape e ka honyela popelo le ho matlafatsa khatello.

    8.Besides, evodiamine e boetse e na le phello e ntle ho lefu la Alzheimer's le stroke.

     

    Kopo:

    1) Meriana e le li-capsules kapa lipilisi;
    2) Lijo tse sebetsang e le li-capsules kapa lipilisi;
    3) Lino tse qhibilihang ka metsing;
    4) Lihlahisoa tsa bophelo bo botle e le li-capsules kapa lipilisi.

  • E fetileng:
  • E 'ngoe: